IVHI — what changed in the latest 10-Q
A section-by-section comparison of IVHI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-12 vs the prior 10-Q · 2026-05-12
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −5 | ~4 | 15 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 11 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-12
Interest expense for the six months ended June 30, 2026, were $ 864 compared to $ -0- for the six months ended June 30, 2025, an increase of $864. The increase in the current period is due to interest being accrued on the amounts owed to a related party.
Amortization expense for the three and six months ended June 30, 2026, were $11,416 and $11,416.
For the six months ended June 30, 2026, the Company had a net loss of $202,739 compared to the six months ended June 30, 2025, of a net loss of $38,880. The increase of net loss is due mostly to increased legal fees accumulated during 2026.
For six months ended June 30, 2026, we used net cash of $ 48,393 in operating activities as compared to $ 39,120 for the six months ended June 30, 2025.
No investing activities occurred during the six months ended June 30, 2026, and 2025.
Text removed vs the prior filing · source: 10-Q · 2026-05-12
Professional fees for the three months ended March 31, 2026, were $52,540 compared to $2,564 for the three months ended March 31, 2025, an increase of $49,976. The increase in the current period is due to an increase in legal fees, including non-cash expense for the granting of common stock of $22,5…
For the three months ended March 31, 2026, the Company had a net loss of $119,313 compared to the three months ended March 31, 2025, of a net loss of $31,377. The increase of net loss is due to the reasons discussed above.
For three months ended March 31, 2026, we used net cash of $39,500 in operating activities as compared to $33,867 for the three months ended March 31, 2025.
No investing activities occurred during the three months ended March 31, 2026, and 2025.
During the three months ended March 31, 2026, the Company received advances of $39,600 from a related party for working capital purposes compared to $33,867 received in the prior period.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice